New CVS and Express Scripts Value Based Plans for Oncology

CVS and Express Scripts recently announced new plans to determine price and access to cancer drugs based on value. Learn more about these plans and others, such as Memorial Sloan Kettering’s Drug Abacus here. (Source: Tracey Walker, 4/3/16)

You might also be interested in:

ICER Signs Multi-Year Deal to Use New Cloud-Based Analytic… 02/20/2020
How HEOR Professionals Can Be Force Multipliers in the Fight… 10/06/2020
Association for Accessible Medicines (AAM) Names Health Care… 08/25/2020
Key Innovations Coming From The Next Generation of PBM’s 08/12/2020
Using AI, NLP and Data Visualization with RWE to Generate… 06/10/2020
HealthEconomics.Com, Scientist.Com Announce HEOR, RWE Partnership 04/10/2020
Government, Big Pharma, and The People: A Century of Dis-Ease 12/03/2020